Edition:
India

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.59USD
20 Sep 2019
Change (% chg)

$0.01 (+1.30%)
Prev Close
$0.58
Open
$0.58
Day's High
$0.59
Day's Low
$0.56
Volume
30,777
Avg. Vol
33,140
52-wk High
$1.25
52-wk Low
$0.49

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.012
FY 2018 Dec '18 0.00 -0.016
Sep '18 0.00 0.172
Jun '18 0.00 -0.200
Mar '18 0.00 0.057
FY 2017 Dec '17 0.00 -0.437
Sep '17 0.00 -0.217
Jun '17 0.00 -0.117
Mar '17 0.00 -0.599
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 2 0.00 0.00 0.00 --
Quarter Ending Dec-19 2 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Year Ending Dec-20 2 4.32 8.65 0.00 35.56
Earnings (per share)
Quarter Ending Sep-19 2 -0.08 -0.07 -0.08 --
Quarter Ending Dec-19 2 -0.08 -0.07 -0.08 --
Year Ending Dec-19 2 -0.22 -0.21 -0.24 --
Year Ending Dec-20 2 -0.22 -0.18 -0.26 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 103.07 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellerophon Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.64 1.73 99 --
13 Week -1.91 -4.70 99 --
26 Week -4.96 -16.30 99 --
52 Week -76.34 -77.81 26 --
YTD -21.76 -35.18 58 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.72%
# of Holders: 31
Total Shares Held: 37,706,901
3 Mo. Net Change: 20,800
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.